Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCIK Combined With DC Treatment for Glioma
NCT01235845Phase 2Unknown
- Sponsor
- Qingdao University
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DC-CIK cells in malignant glioma, sponsored by Qingdao University. Status: unknown.
02
Drugs
DC-CIK cells
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01235845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235845.